Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Christopher-Stine

Showing results (1-10 of 208) with videos related to

Pageof 21
Sort By:
Current Opinion in Rheumatology|September 16, 2010
Neurologists are from Mars. Rheumatologists are from Venus: differences in approach to classifying the idiopathic inflammatory myopathiesLisa Christopher-Stine
Current Opinion in Rheumatology|October 21, 2006
Statin myopathy: an updateLisa Christopher-Stine
The Journal of Rheumatology|May 15, 2026
From Serendipity to Science: How Anti-HMGCR Antibodies Changed Our Understanding of MyositisLisa Christopher-Stine
The Journal of Rheumatology|January 14, 2004
Tumor necrosis factor-alpha antagonists induce lupus-like syndrome in patients with scleroderma overlap/mixed connective tissue diseaseLisa Christopher-Stine, Fredrick Wigley
Current Rheumatology Reports|April 29, 2010
Drug-related myopathies of which the clinician should be awareRitu Valiyil, Lisa Christopher-Stine
Rheumatic Diseases Clinics of North America|October 29, 2025
Autoantibodies in Myositis: Can They Predict Disease Course?Eugene Krustev, Lisa Christopher-Stine
Rheumatology and Immunology Research|December 5, 2022
Myositis-specific Antibodies: Overview and Clinical UtilizationFatima Halilu, Lisa Christopher-Stine
Current Opinion in Lipidology|February 17, 2017
Statin-associated immune-mediated myopathy: biology and clinical implicationsLisa Christopher-Stine, Pari Basharat
Rheumatology (Oxford, England)|June 3, 2024
Breaking down statin myopathy: understanding the self-limited and autoimmune subtypesJoel Wright, Lisa Christopher-Stine
Rheumatic Diseases Clinics of North America|March 30, 2011
Polymyositis, dermatomyositis, and autoimmune necrotizing myopathy: clinical featuresSabiha Khan, Lisa Christopher-Stine
Pageof 21

Showing results (1-10 of 208) with videos related to

Sort By:
Pageof 21
Current Opinion in Rheumatology|September 16, 2010
Neurologists are from Mars. Rheumatologists are from Venus: differences in approach to classifying the idiopathic inflammatory myopathiesLisa Christopher-Stine
Current Opinion in Rheumatology|October 21, 2006
Statin myopathy: an updateLisa Christopher-Stine
The Journal of Rheumatology|May 15, 2026
From Serendipity to Science: How Anti-HMGCR Antibodies Changed Our Understanding of MyositisLisa Christopher-Stine
The Journal of Rheumatology|January 14, 2004
Tumor necrosis factor-alpha antagonists induce lupus-like syndrome in patients with scleroderma overlap/mixed connective tissue diseaseLisa Christopher-Stine, Fredrick Wigley
Current Rheumatology Reports|April 29, 2010
Drug-related myopathies of which the clinician should be awareRitu Valiyil, Lisa Christopher-Stine
Rheumatic Diseases Clinics of North America|October 29, 2025
Autoantibodies in Myositis: Can They Predict Disease Course?Eugene Krustev, Lisa Christopher-Stine
Rheumatology and Immunology Research|December 5, 2022
Myositis-specific Antibodies: Overview and Clinical UtilizationFatima Halilu, Lisa Christopher-Stine
Current Opinion in Lipidology|February 17, 2017
Statin-associated immune-mediated myopathy: biology and clinical implicationsLisa Christopher-Stine, Pari Basharat
Rheumatology (Oxford, England)|June 3, 2024
Breaking down statin myopathy: understanding the self-limited and autoimmune subtypesJoel Wright, Lisa Christopher-Stine
Rheumatic Diseases Clinics of North America|March 30, 2011
Polymyositis, dermatomyositis, and autoimmune necrotizing myopathy: clinical featuresSabiha Khan, Lisa Christopher-Stine
Pageof 21